Inadequate ventilation of intubated patients during transport from the operating theatre to the intensive care unit with attendant hypercarbia may adversely affect haemodynamics. In a retrospective observational study, we assessed the incidence of inadequate ventilation during transport from the operating theatre to the intensive care unit in 99 consecutive cardiac surgery patients admitted to our university tertiary hospital.
Monitoring of the adequacy of ventilation in mechanically or manually ventilated patients during transport from the operating theatre to the intensive care unit (ICU) relies on non-invasive parameters, predominantly end-tidal carbon dioxide (ETCO 2 ) and oxygen saturation (SpO 2 ). Variation of partial pressure of carbon dioxide (P a CO 2 ) is not uncommon in anaesthetic practice. Inadequate ventilation during transport with attendant hypercarbia may adversely affect haemodynamics. Adverse events, such as change in heart rate, arterial hypotension and hypertension, arrhythmias, a change in respiratory rate and cardiac arrest occur in up to 70% of transports 1 . At least some of these events could be caused by inadvertent hypercarbia, as CO 2 is both a stimulant to the sympathetic nervous system and a direct vasodilator 2, 3 . Hypercarbia affects heart rate, contractility and left ventricular ejection time 4 , all of which have significant implications for patients following cardiac surgery. However, despite these theoretical concerns, the value of monitoring minute ventilation or ETCO 2 is unclear.
We hypothesised that intubated and ventilated patients after cardiac surgery in our hospital were being inadvertently hypoventilated during transport to the ICU, leading to hypercarbia. If this proved to be the case, we wished to explore which factors were associated with an elevated P a CO 2 . Furthermore, on physiological grounds [5] [6] [7] and with early clinical evidence 8 , we hypothesised that hypercarbia might have the particularly detrimental adverse effect of increasing pulmonary artery pressure. By exploring the other possible influences on pulmonary artery pressure we sought to determine whether any such association was independent of confounding.
METHODS
We retrospectively evaluated 99 consecutive cardiac surgical patients admitted to our ICU in 2009. We collected demographic information and noted the intraoperative use of inotropes and analgesia. We analysed the first set of arterial blood gas and haemodynamic measurements (including pulmonary artery pressure) obtained immediately after admission to the ICU. According to our standard written protocol, the haemodynamic measurements recorded are the first observed immediately after the establishment of ICU monitoring. Blood is drawn for arterial blood gas (ABG) analysis by a nurse whose only other prior tasks are to check patient position and equipment serviceability. Typically this results in the ABG being drawn approximately five minutes after ICU arrival. We recorded any adverse events in the ICU admission along with ICU and hospital length of stay and mortality.
The distance from operating theatre to intensive care unit is approximately 300 metres. Only the electrocardiogram, invasive arterial blood pressure, pulmonary artery pressure and arterial oxygen saturation (SpO 2 ) are monitored during transport. End-tidal carbon dioxide is never measured. Patients are routinely ventilated using a manual bag-valvemask apparatus except in cases when the anaesthetist feels there would be particular benefit in calling for a transport ventilator.
Summary data are presented according to categories pre-determined by clinical relevance. Non-parametric indices are reported for all numeric data in addition to parametric measures in cases where visual inspection showed a normal distribution. Between-group comparisons of continuous data were made using the Mann-Whitney U test while categorical outcomes wereassessed using Fisher's exact test or chi-square test as appropriate. Univariate associations were assessed using conventional least-squares regression, and multivariate models were constructed incorporating allavailable demographic, haemodynamic, blood gas, pharmacologic and intraoperative details, using backwards stepwise regression with P <0.1 for retention. Statistical significance in all cases was defined as P <0.05.
RESULTS
The mean age of patients studied was 65 years, with most (62.7%) having coronary artery bypass grafts (CABG) alone, 22.2% having valvular surgery alone, and 7% having both CABG and valvular surgery. Sixty-nine percent of patients arrived on an inotrope infusion, either noradrenaline (53.5%) or milrinone (15.1%). In accordance with our protocol, no other inotropes were used. Despite substantial doses of intraoperative morphine, most patients (85%) arrived in ICU on a propofol infusion. Eleven percent of patients were mechanically ventilated during transport (Table 1) . No patients died during their hospital admission; other outcomes are listed in Table 1 .
On arrival in the ICU, median P a CO 2 level was 42 mmHg ( Table 2 ). However, nearly half of the patients were being improperly ventilated, with 18.2% having P a CO 2 <35 mmHg and 28.3% of patients with P a CO 2 >45 mmHg. The average mean pulmonary artery pressure (MPAP) was 23.8 mmHg, with nearly half (48.5%) having moderate (≥25 mmHg) and 17.2% severe (≥30 mmHg) Half the cohort had an elevated lactate (>2 mmol/l). As expected, pH was strongly associated (R 2 =0.6, P <0.0001) with P a CO 2 , and this association was strengthened when lactate was added to the model (R 2 =0.67, P <0.0001). Contrary to expectation, hypercarbia (P a CO 2 >45 mmHg) and hypocarbia (P a CO 2 <35 mmHg) were not significantly associated with any adverse outcome ( Tables 3 and 4 ). However, most patients (75%) with an elevated P a CO 2 arrived in ICU on an inotrope infusion, while this was true of only 48% who were not hypercarbic (P <0.014). In contrast, hypocarbia was not significantly associated with the need for inotropes.
No demographic indices or recorded aspects of intraoperative management were found to predict an abnormally high P a CO 2 , although the association with greater age approached significance (P=0.054). Twelve different anaesthetists were responsible for management of the 99 patients. In univariate regression, four were significantly more likely to arrive with a patient with a P a CO 2 ≥45 mmHg. When 'anaesthetist' was added to the previously considered variables as a potential predictor of P a CO 2 ≥45 mmHg, three of these four remained independently associated with this outcome. One of the other anaesthetists was significantly less likely to deliver a hypercarbic patient. This anaesthetist routinely used a transport ventilator. This anaesthetist was also significantly less likely to have a patient suffer a complication in the ICU.
Pulmonary artery pressure was not associated with P a CO 2 in either univariate analysis (R 2 =0.0076, P=0.39; Figure 1 ) or after adjustment for all measured potential confounders. Multivariate analysis found the only significant predictors of higher MPAP were a higher central venous pressure, having had an operation other than CABG alone, intraoperative use of alfentanil, use of noradrenaline at the time of ICU admission, lower base excess and lower P a O 2 ( Table 5 ). Only four anaesthetists used alfentanil. When use of alfentanil was taken into account, the anaesthetist involved was not a significant predictor of MPAP. The use of alfentanil is therefore not a marker for some other (unobserved) aspect of anaesthetic technique. The median MPAP was higher in patients receiving noradrenaline (26 mmHg) compared to 22 mmHg in all others (P <0.0008). MPAP did not significantly predict any adverse outcome in either univariate or multivariate analyses.
DISCUSSION
We that found that inappropriate ventilation resulting in either hypercarbia or hypocarbia is common, but does not seem to be associated with any measurable adverse outcome other than the increased requirement for noradrenaline amongst those who had a P a CO 2 >45 mmHg. Our finding is not without precedent in the literature. Hypothesising hypercarbic acidosis would provide improved recovery of the stunned myocardium following cardiac surgery in lambs, Nomura et al 9 found the hypercarbic acidotic group had improved indices of contractility, coronary blood flow and myocardial oxygen consumption. Morisaki et al 10 studied patients with chronic lung disease during thoracic surgery and found that hypercarbia during anaesthesia may not be associated with serious consequences, although all patients required inotropic support to prevent hypotension. Others have suggested mild hypercarbia may be beneficial, provided anaesthetists are familiar with the physiological effects of carbon dioxide and titrate it to their patient's condition 11 . This review cited evidence that hypercarbia improves tissue perfusion and oxygenation, and preserves cerebral blood flow, although it concluded these findings needed to be prospectively evaluated before being considered for clinical application 11 . Notwithstanding our inability to identify any patient-centred adverse effects of hypercarbia, we observed that patients with higher P a CO 2 were also those who tended to require noradrenaline. If the higher noradrenaline requirement is caused by the higher P a CO 2 , this could be because vasodilation caused by hypercarbia 2 is not outweighed by the effect of increased CO 2 on sympathetic tone in these patients. Perhaps sympathetic tone was near maximal immediately following cardiac surgery. However, we have no evidence to support the causal nature of this relationship. It may be that noradrenaline causes hypercarbia (although unlikely, perhaps because profound pulmonary vasoconstriction increases physiological deadspace), or more plausibly, that a third factor -such as physiological instability -leads to both hypercarbia (through inattention to proper ventilation) and a higher noradrenaline requirement.
We could not identify any measured clinical factor that predicted arrival with a higher P a CO 2 . However, some (unmeasured) aspect of the technique of three of the 12 anaesthetists was significantly associated with hypercarbia, while one anaesthetist was significantly less likely to deliver a patient in this state. This may have been because it was this anaesthetist's usual practice to use a mechanical transport ventilator. Curiously, this anaesthetist was also independently associated with a lower risk of reported complications (such as myocardial infarction, new renal impairment, haemorrhage, pericardial tamponade and cardiogenic shock). We did not explore further the possible explanations for this observation, which might conceivably include a propensity to work with particular surgeons, unmeasured differences in patient comorbidity, or differences in anaesthetic technique. Nonetheless, while it was not the focus of our study, we reflect that data collection and analysis with this degree of detail is an ideal starting point for a system of qualitative quality assurance within an anaesthetic department. Variability in practice can only be justified if there is no systematic association between a particular approach and adverse outcomes, or plausible surrogates for adverse outcomes. On the basis of our results we hypothesise, for example, that monitoring of ETCO 2 , routine use of mechanical ventilation for transport, or both, might reduce the incidence of suboptimal ventilation during transport.
We were surprised to find no significant association between MPAP and P a CO 2 at the time of arrival in the ICU. Tempe et al 12 tested the effect of mild hypercarbia on right ventricular function in patients having mitral valve surgery, most of whom had pulmonary hypertension. They found that mild hypercarbia (P a CO 2 51.5±3.7 mmHg) significantly increased pulmonary vascular resistance, mean pulmonary arterial pressure, right ventricular stroke work, right ventricular systolic pressure and right ventricular end-diastolic pressure. The effect was not totally reversible with CO 2 washout, as all parameters except right ventricular end-diastolic pressure and pulmonary vascular resistance continued to remain elevated when normocarbia was restored. The authors suggested continuous monitoring of endtidal CO 2 and frequent blood gas analysis. In our group of patients, we did not differentiate the effect of hypercarbia on those with pre-existing pulmonary hypertension. Patients with pulmonary hypertension may be particularly sensitive to changes in CO 2 , especially hypercarbia. Avidan et al 13 showed that when exogenous CO 2 was added to inhaled oxygen, pulmonary pressure increased with elevations in P a CO 2 (in the range 30 to 50 mmHg), a statistically significant (P <0.001) association. That we did not observe this association between P a CO 2 and MPAP is probably explained by the fact that the studies of Tempe and Avidan looked for the effect on MPAP as P a CO 2 was varied in individual patients, whereas we made only one measurement of MPAP and P a CO 2 in each patient. Despite our attempts to adjust for factors that might confound the relationship between these two variables using multivariate regression, it is likely that residual confounding obscured the association. We therefore neither confirm nor refute this previously described association, but note that if indeed P a CO 2 is a determinant of MPAP, in clinical practice there are quantitatively more important influences on pulmonary vascular tone and pressure.
While P a CO 2 did not predict higher MPAP, we identified several other factors that did. The association with central venous pressure is expected from an understanding of cardiovascular physiology, but the possible mechanisms whereby CABG surgery (as opposed to other procedures) and use of alfentanil also influence MPAP remain speculative. It may have been that anaesthetists were using alfentanil to treat higher MPAP, but as anaesthetists tended to always use, or never use, alfentanil, in reality this is most likely to be a spurious association. Noradrenaline causes pulmonary vasoconstriction (albeit to a lesser extent than in the systemic circulation) 14 , as does acidosis, and hypoxic pulmonary vasoconstriction is well described 14 , so it is reassuring that our audit identified these factors as significant predictors of MPAP. However, the relationship between noradrenaline, acidosis and MPAP may not be causal, but rather due to severity of illness causing all three to increase in concert. Our study does not allow us to conclude which of these possibilities is the more likely.
Our study has several strengths. There was no bias to our patient selection or data collection, as we studied consecutive patients without omission and we routinely make all the measurements reported immediately on patient arrival in the ICU. The retrospective nature of our study is an advantage, as the anaesthetists involved could not modify their practice knowing their results were being scrutinised. Although previous studies have demonstrated adverse effects of hypercarbia, none have studied such a large number of patients in the highly typical clinical context of postoperative transport.
There are also several limitations to this retrospective observational study. We did not study the effect of hypercarbia on the subset of patients with pre-existing pulmonary hypertension or those with pre-existing lung conditions resulting in preoperative hypercarbia. However, few patients arrived in the ICU with very high postoperative pulmonary artery pressures, suggesting significant preoperative pulmonary hypertension was uncommon. An anaesthetised patient under normothermic conditions without lung disease in the supine position has a gradient of 6±3 mmHg between P a CO 2 and end-tidal CO 2 (ETCO 2 ) 15, 16 . Although our patients were supine, anaesthetised and normothermic, they may have had a much larger difference between P a CO 2 and ETCO 2 due to pre-existing lung pathology or other factors. We did not measure the difference between P a CO 2 and ETCO 2 in our study. However, provided the anaesthetist noted the difference between ETCO 2 and P a CO 2 intraoperatively, it is reasonable to expect the optimal ETCO 2 could be maintained during transport. We found no significant adverse effect of hyper-or hypocarbia or a high MPAP, but this may have been because we studied an insufficient number of patients with substantially abnormal values. Certainly, we would expect that sustained elevated MPAP should be associated with poorer outcome 17 .
CONCLUSION
This study has identified that patients who are acidotic, hypoxic and requiring inotrope infusions on arrival in the ICU are at particularly high risk of also having a higher postoperative MPAP. If elevated MPAP is indeed associated with worse outcomes (an association that we may not have demonstrated due to insufficient numbers studied), patients may derive benefit from correction of acidosis and hypoxia, and measures to limit the use of inotropic support, if indeed these associations are causative. Furthermore, if the association we observed between hypercarbia and inotrope requirement is causal, and if inotrope requirement is associated with poor outcome, patients may derive benefit from more close attention to monitoring and adjusting P a CO 2 during transport. We suggest these factors may be appropriate targets for future interventional studies. In the meantime, it would be prudent to observe extra caution during transport of patients with acidosis, hypoxia, hypercarbia and who require inotropes.
